Please login to the form below

Not currently logged in
Email:
Password:

top 10

This page shows the latest top 10 news and features for those working in and with pharma, biotech and healthcare.

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Total product sales fell 10% to $5.1bn in the second quarter of the year, compared to $5.6bn in the same quarter last year and below analyst expectations.

Latest news

More from news
Approximately 0 fully matching, plus 94 partially matching documents found.

Latest Intelligence

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    n = 36. PRIME isn’t just for big companies: up to March 2018 just nine of the companies - with 10 PRIME treatments - are in the top 50 companies of 2017 by ... sales, and 6 are in the top 10 companies with Pfizer (with Spark Therapeutics), Novartis (by

  • The good, the bad and the ugly The good, the bad and the ugly

    The second half of the top 10 European companies is taken up by five companies that do not feature among the top 10 global pharma. ... The latter enjoyed a sales uplift of 16.3%, making it one of seven companies in the top 10 outfits to deliver strong

  • The tipping point The tipping point

    If we project forward to 2020, seven of the top 10 global medicines by spend will be biologics. ... If we take the top 20 biologics by spend, in two years, 15 of these will have biosimilars.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    Two of the top 10 biopharma companies (GSK and AstraZeneca) have UK HQs and nearly 10% of the top 100 drugs available today originated from UK-based research. ... Moreover, it has been estimated that a further 10.0bn of funding is at risk by 2020.

  • Deal Watch March 2017 Deal Watch March 2017

    top 10 in the previous three months. ... Indeed, only 10 deals are at the $100m and above level and this month’s Top 20 includes deals with single figure headlines.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 28 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics